FD Technologies Ltd.

Director's Dealing • Jul 17, 2025

National Storage Mechanism | Additional information

RNS Number : 5401R

FD Technologies PLC

17 July 2025

17 July 2025

FD Technologies plc

PDMR Notice and Issue of Equity

FD Technologies plc (the "company") (AIM: FDP.L, Euronext Growth: FDP.I) announces that on 17 July 2025 the Company allotted 1,059,184 new ordinary shares of £0.005 each in the Company ("the Ordinary Shares") following the vesting of awards granted under the Company's long term incentive plan and the exercise of options granted under the Company's unapproved employee share scheme.

Application has been made for the new Ordinary Shares to be admitted to trading on AIM and Euronext Growth and it is expected that admission will take place on 18 July 2025. The new Ordinary Shares will rank pari passu with the existing shares of the Company. Following these allotments, the total issued share capital of the Company will increase to 23,256,424 ordinary shares.

Enquiries

For further information please contact:

FD Technologies plc Derek Brown, Head of Investor Relations	+44(0)28 3025 2242 www.fdtechnologies.com
Investec Bank plc (Nominated Adviser and Broker) Carlton Nelson Virginia Bull	+44 (0) 20 7597 5970
FTI Consulting LLP (Financial PR) Matt Dixon Dwight Burden Victoria Caton	+44 (0) 20 3727 1000 FDtechnologies@fticonsulting.com

About KX

KX is on a mission to make AI a commercial reality for the many by addressing data challenges that impede deployment at scale. By simultaneously ingesting and analysing high volumes of historical and real-time data, KX's AI-ready analytical database enables organizations to unlock the full value of their data to accelerate innovation and make faster, more confident decisions.

KX is the world's most performant, cost-effective and energy-efficient analytical database, delivering advanced data algorithms, insights and analytics at unmatched scale and speed.  KX is trusted by the world's top investment banks, Aerospace and Defence, high-tech manufacturing and health and life sciences organizations and operates across North America, Europe, and Asia Pacific.

For further information, please visit www.fdtechnologies.com

For further information, please visit www.fdtechnologies.com and www.kx.com

1.

Details of PDMR / person closely associated with them ("PCA ")

a)

Names

Seamus Keating, Ryan Preston and Ashok Reddy

2.

Reason for the notification

a)

Positio n / status

Seamus Keating - Chief Executive Officer of FD Technologies

Ryan Preston - Chief Financial Officer of FD Technologies

Ashok Reddy - Chief Executive Officer of KX

b)

Initial notification / amendment

Initial Notification

3.

Details of the Issuer

a)

Name

FD Technologies plc

b)

LEI

213800MKQAJ5R7WIU633

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, t ype of instrument

Ordinary Shares of £0.005

ISIN: GB0031477770 

b)

Nature of the transaction

Shares acquired following the vesting of awards under the Company's long term incentive plan and the exercise of options granted under the Company's unapproved employee share scheme. 

c)

Price(s) and volume(s)

Seamus Keating

Plan	Price(s)	Volume(s)
Long term incentive plan	£0.005	143,514

Ryan Preston

Plan	Price(s)	Volume(s)
Long term incentive plan	£0.005	38,270
Unapproved employee share scheme	£22.350	30,000

Ashok Reddy

Plan	Price(s)	Volume(s)
Long term incentive plan	£0.005	58,093
Unapproved employee share scheme	£18.720 £17.500	150,000 £50,000

d)

Aggregated information

-     Aggregated volume

-     Price

Seamus Keating:143,514

Ryan Preston: 68,270

Ashok Reddy: 258,093

Seamus Keating: £0.005

Ryan Preston: £9.824

Ashok Reddy: £14.271

e)

Date of the transaction

17 July 2025

f)

Place of the transaction

London Stock Exchange (XLON)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

IOERRMJTMTTBBPA